Cartalax 10mg/BPC-157 5mg/TB-500 (TB4) 5mg
Janoshik
Batch CTBT-CA-26F-20
- Cartalax
- 10.72 mg
- BPC-157
- 5.98 mg
- TB-500 (TB4)
- 5.75 mg
Deadpool - Cartalax 10mg/ BPC-157 5mg/TB-500 5mg
Recovery Blend
Also known as Cartalax 10mg + BPC-157 5mg + TB-500 5mg
Wolverine+ is a research blend supplying cartalax, BPC-157, and TB-500 in a single vial.
Mix & Match
1 vial — no vial discount yet.
Add 2 more vials for 5% off.
After that, 10% at 5 vials, 20% at 10 vials.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Wolverine+ is a research blend supplying cartalax, BPC-157, and TB-500 in a single vial.
Each component is separately studied in tissue-repair research; the combination itself has no published literature.
Wolverine+ combines a short peptide bioregulator associated with cartilage models (cartalax, Ala-Glu-Asp) with two peptides that recur in tissue-repair research. BPC-157 is a synthetic fragment of a gastric protein studied for angiogenic and inflammatory signaling. TB-500 corresponds to an active region of thymosin beta-4, studied for actin binding and cell migration.
The combination is a formulation choice. References below are drawn from the component literature.
The components entered research independently: BPC-157 through gastric-protein fragment work, thymosin beta-4 through actin-sequestering protein research, and cartalax through the short-peptide bioregulator programme.
The blend has no separate development history and is a supplier formulation.
Research relevant to Wolverine+ is the sum of its components: angiogenic and inflammatory signaling, actin-binding and cell migration, and short-peptide regulation in connective-tissue models. No study has evaluated this specific three-component combination.
2 of the 4 areas below are addressed directly by a paper cited on this page.
Angiogenic and inflammatory signaling (BPC-157)
No paper cited on this page reports on angiogenic or inflammatory. This heading marks where Deadpool is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Actin-binding and cell-migration research (TB-500)
Addressed on this page by Bock-Marquette 2004, Ashapkin 2020. The work appeared in Nature. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Bock-Marquette, I. et al. (2004) — Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432(7016):466–472.
- Ashapkin, V. et al. (2020) — Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides.
Connective-tissue bioregulator models (cartalax)
No paper cited on this page reports on connective, tissue or bioregulator. This heading marks where Deadpool is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Combined tissue-repair formulation frameworks
Addressed on this page by Bock-Marquette 2004. The work appeared in Nature. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Bock-Marquette, I. et al. (2004) — Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432(7016):466–472.
The references section of this page cites 5 primary papers published between 1993 and 2020 — a limited but non-trivial record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Deadpool, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Deadpool is commonly described online in connection with faster healing from injury and improved recovery. In the research literature the same compound is filed under angiogenic and inflammatory signaling (BPC-157), actin-binding and cell-migration research (TB-500) and connective-tissue bioregulator models (cartalax).
The 5 papers cited on this page, published between 1993 and 2020 (1 in animal models and 1 review) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
The lot code printed on the vial matches the code on the certificate for Deadpool. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Deadpool in the United States through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Bacteriostatic water in most published protocols
- Format
- Lyophilized powder
Deadpool is a co-lyophilized blend — more than one compound freeze-dried together in a single vial. Handling follows the least stable component rather than an average, and the same is true of storage: the constraint that binds is whichever compound in the vial is most sensitive.
Reconstituting a blend does not separate its components, so a blend cannot be split into its parts after the fact. That is why per-component content verification matters more here than a single blended purity figure — the ratio inside the vial is fixed at manufacture and cannot be corrected downstream.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
- 1 × sealed glass vial in the strength selected (20mg / Single Vial, 20mg / 5-Pack, 20mg / 10-Pack available), batch-labelled
- The batch-linked Certificate of Analysis for the exact lot shipped
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of Wolverine+. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313–327.
PubMedGastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res 21(6):976–983.
PubMedThymosin beta4 accelerates wound healing. J Invest Dermatol 113(3):364–368.
PubMedThymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432(7016):466–472.
PubMedGene expression in human mesenchymal stem cell aging cultures: modulation by short peptides.
PubMedRelated
You May Also Like
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$49.99
Synthetic thymosin beta analog studied for cellular migration, actin regulation, and repair signaling pathways
From$59.99
TB-500 Fragment 17-23 is the seven-residue actin-binding region of thymosin beta-4, studied in research on tissue repair and cell migration.
From$44.99
Tripeptide studied for anti-inflammatory signaling, immune modulation, and cellular response pathways
From$49.99